|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2017 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III, JD |
Date | 7/20/2017 9:51:21 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
FY 2018 Appropriations - Funding to combat Zika Virus
Appropriations - Comprehensive Addiction and Recovery Act (CARA) funding
Appropriations - Prescription Drug Monitoring Program (PDMP) funding
Appropriations - Funding to combat Opioid Abuse
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 394, Restoring Access to Medication Act of 2017, all provisions
S. 85, Restoring Access to Medication Act of 2017, all provisions
H.R. 1732, Synthetic Drug Control Act of 2017, all provisions
H.R. 1628, American Health Care Act of 2017, all provisions
H.R. 496, Bar Removal of Individuals who Dream and Grow our Economy (BRIDGE) Act, all provisions
S. 128, Bar Removal of Individuals who Dream and Grow our Economy (BRIDGE) Act, all provisions
H.R. 1057, Synthetics Trafficking and Overdose Prevention Act of 2017, all provisions
S. 372, Synthetics Trafficking and Overdose Prevention (STOP) Act of 2017, all provisions
H.R. 1270, Living Donor Protection Act of 2017, all provisions
H.R. 1224, NIST Cybersecurity Framework, Assessment, and Auditing Act of 2017, all provisions
H.R. 1375, Prescriber Support Act of 2017, all provisions
H.R. 1370, Department of Homeland Security Blue Campaign Authorization Act of 2017, proposed amendment on physicians in ICE facilities
H.R. 365, Primary Care Enhancement Act of 2017, all provisions
Better Care Reconciliation Act of 2017
Affordable Care Act (ACA) Repeal/Replace
MacArthur Amendment to H.R. 1628
American Health Care Act
Preventive Health Savings Act
National Clinical Care Commission Act
Health Care Reform
ACA Cost-sharing reduction funding
Laboratory Developed Testing Regulation and Oversight
Opioid Abuse
Telemedicine
EHR certification/Stage 3 Meaningful Use
Health Savings Accounts - Prescription requirement for over-the-counter medications
Immigration
Prescription Drug Pricing
Health IT
HIPAA: Audit program, cybersecurity, and patient access
Regulatory Relief
FDA small practice/solo physician group policies
Diabetes
Individual health insurance market
Precision Medicine
National Quality Forum
Digital Medicine
Coding - Alternative Payment Models, Digital Medicine
Unique Patient Identifier
Sale of health insurance across state lines
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Office of Natl Drug Control Policy (NDCP), Food & Drug Administration (FDA), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Kristen |
O'Brien |
|
|
|
Sylvia |
Trujillo |
|
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
H.R. 2141, Conrad State 30 and Physician Access Reauthorization Act, all provisions
S. 898, Conrad State 30 and Physician Access Reauthorization Act, all provisions
Licensure
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
George |
Cox |
III |
|
|
Kristen |
O'Brien |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 2556, CONNECT for Health Act of 2017, all provisions
S. 1016, CONNECT for Health Act of 2017, all provisions
H.R. 849, Protecting Seniors' Access to Medicare Act of 2017, all provisions
S. 260, Protecting Seniors' Access to Medicare Act of 2017, all provisions
H.J.Res.51, Approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act, all provisions
S. 251, Protecting Medicare from Executive Action Act of 2017, all provisions
H.R. 1628, American Health Care Act of 2017, all provisions
H.R. 930, Lymphedema Treatment Act, all provisions
S. 497, Lymphedema Treatment Act, all provisions
H.R. 2267, Resident Physician Shortage Reduction Act of 2017, all provisions
S. 1301, Resident Physician Shortage Reduction Act of 2017, all provisions
H.R. 1156, Patient Access to Higher Quality Health Care Act of 2017, all provisions
S. 1133, Patient Access to Higher Quality Health Care Act of 2017, all provisions
S. 794, Local Coverage Determination Clarification Act of 2017, all provisions
S. 479, Removing Barriers to Colorectal Cancer Screening Act of 2017, all provisions
S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017, all provisions
S. 1169, Medicaid Coverage for Addiction Recovery Expansion Act, all provisions
H.R. 2077, Restoring the Patient's Voice Act of 2017, provisions relating to electronic prior authorization requirements/Part D Drugs
Medicare program: Creating Access to Residency Education Act
Medicare program: ACO Improvement Act
Medicare program: Protecting Access to Medicare Act (PAMA)/ Point of care testing
Medicare program: Independent Payment Advisory Board (IPAB) Repeal
Medicare program: Meaningful Use
Medicare program: Regulatory relief
Medicare program: Graduate Medical Education
Medicare program: Medicare Advantage
Medicare program: Physician fee schedule
Medicare program: MACRA implementation
Medicare program: MACRA alternative payment models
Medicare program: MACRA Meaningful Use burden
Medicare program: Quality Payment Program (QPP)
Medicare program: Merit-based Incentive Payment System (MIPS)
Medicare program: Social Security Number Removal Initiative
Medicare program: Pharmacy Benefit Manager (PBM)
Medicare program: Health IT burden
Medicare program: Physician Compare
Medicare program: Qualified Clinical Data Registries
Medicare program: Global Surgical Codes
Medicare program: Open Payments
Medicare program: Part B Drugs
Medicare program: Site of service issues
Medicare program: Clinical Laboratory Fee Schedule reform implementation
Medicare program: Diabetes
Medicare program: Provider Enrollment, Chain, and Ownership System (PECOS)
Medicare program: Local Coverage Determination
Medicare and Medicaid programs: Stark Law reforms
Medicare and Medicaid programs: CMS Open Payments FOIA request
Medicare and Medicaid programs: Childrens Health Insurance Program (CHIP)
Medicare and Medicaid programs: HIPAA: Audit program, cybersecurity, and patient access
Medicaid program: Affordable Care Act
Medicaid program: Institutions for Mental Diseases (IMD) exclusion
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Ashley |
McGlone |
|
|
|
Kristen |
O'Brien |
|
|
|
Sylvia |
Trujillo |
|
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Tax Reform - Accounting Methods
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Thomas |
Roberge |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
FDA deeming rule/regulatory jurisdiction extension
17. House(s) of Congress and Federal agencies Check if None
Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 1876, Good Samaritan Health Professionals Act of 2017, all provisions
S. 781, Good Samaritan Health Professionals Act of 2017, all provisions
H.R. 1215, Protecting Access to Care Act of 2017, all provisions
H.R. 1704, Accessible Care by Curbing Excessive lawSuitS (ACCESS) Act of 2017, all provisions
Medical Liability Reform
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
S. 925, Veterans E-Health and Telemedicine Support (VETS) Act of 2017, all provisions
H.R.1662, To amend title 38, United States Code, to prohibit smoking in any facility of the Veterans Health Administration, and for other purposes, all provisions
VA Choice program
VA Committee and Telehealth Services for Vets
Department of Veterans Affairs Physician Hiring Practices
Scope of Practice
TRICARE access
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
Lawyer advertising
17. House(s) of Congress and Federal agencies Check if None
Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
George |
Cox |
III |
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |